As of 2024-12-11, the EV/EBITDA ratio of Conmed Corp (CNMD) is 8.82. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CNMD's latest enterprise value is 3,211.06 mil USD. CNMD's TTM EBITDA according to its financial statements is 363.90 mil USD. Dividing these 2 quantities gives us the above CNMD EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 17.4x | 16.4x |
| Forward P/E multiples | 18.8x - 36.8x | 28.2x |
| Fair Price | 66.09 - 176.24 | 138.62 |
| Upside | -11.6% - 135.8% | 85.5% |
| Date | EV/EBITDA |
| 2024-12-10 | 8.82 |
| 2024-12-09 | 8.82 |
| 2024-12-06 | 8.61 |
| 2024-12-05 | 8.64 |
| 2024-12-04 | 8.74 |
| 2024-12-03 | 8.84 |
| 2024-12-02 | 8.93 |
| 2024-11-29 | 8.76 |
| 2024-11-27 | 8.69 |
| 2024-11-26 | 8.75 |
| 2024-11-25 | 9.06 |
| 2024-11-22 | 8.84 |
| 2024-11-21 | 8.57 |
| 2024-11-20 | 8.48 |
| 2024-11-19 | 8.57 |
| 2024-11-18 | 8.49 |
| 2024-11-15 | 8.61 |
| 2024-11-14 | 8.52 |
| 2024-11-13 | 8.90 |
| 2024-11-12 | 8.83 |
| 2024-11-11 | 8.83 |
| 2024-11-08 | 8.71 |
| 2024-11-07 | 8.83 |
| 2024-11-06 | 8.90 |
| 2024-11-05 | 8.76 |
| 2024-11-04 | 8.46 |
| 2024-11-01 | 8.46 |
| 2024-10-31 | 8.27 |
| 2024-10-30 | 8.02 |
| 2024-10-29 | 7.97 |
| 2024-10-28 | 7.89 |
| 2024-10-25 | 7.76 |
| 2024-10-24 | 7.77 |
| 2024-10-23 | 7.77 |
| 2024-10-22 | 7.83 |
| 2024-10-21 | 7.90 |
| 2024-10-18 | 8.11 |
| 2024-10-17 | 7.97 |
| 2024-10-16 | 8.04 |
| 2024-10-15 | 7.98 |
| 2024-10-14 | 7.96 |
| 2024-10-11 | 7.91 |
| 2024-10-10 | 7.73 |
| 2024-10-09 | 7.83 |
| 2024-10-08 | 7.91 |
| 2024-10-07 | 7.92 |
| 2024-10-04 | 8.13 |
| 2024-10-03 | 8.13 |
| 2024-10-02 | 8.20 |
| 2024-10-01 | 8.28 |